Cannabis-based products are manufactured, mainly, from oils obtained from a synthetic way as Dronabinol or obtained from plants of genus Cannabis, as Cannabidiol (CBD) oils. The oils of medicinal-grade cannabis can be delivered using different dosages forms such as: tintures; inhalant; pills, liquids gel, oils, creams, patch; Chewing-gum; capsules, among others.
Select the appropriate dosage form play an important role in the success of the drug product because the dosage form selected should be able to protect the drug substance during all the shell life and facilitate its handling and administration to the patients.
This Webinar refers to Cannabis-based products manufactured in soft gelatin capsules. This webinar was divided in two sections. In the first section we will shows a brief information about plants of cannabis and its most important components delta 9-tetrahydrocannabinol [THC] and Cannabidiols (CBD), then we will explain its clinical relevance and bioavailability.
In the second section we will describe the characteristics of the Soft Gelatin Capsules (SGC) as dosage form and its advantages to be used as the primary dosage form to develop cannabis-based products. Then we will talk about our experience developing cannabis-base products in SGC and the versatility offered for this dosage form. Finally, we will present our conclusion and we will open a Q&A space.
Key Learning Objectives
- To shows the advantages of the manufacture of cannabis-based products in soft gelatine capsules
- To describe the cannabis and its clinical relevance
- To shows the advantages of soft gelatine capsules
